Key Takeaways
- The coffee chain releases Q3 fiscal 2026 results Wednesday following market close
- Analyst consensus points to $0.65 earnings per share and $9.12B in revenue, marking a 3.6% year-over-year drop
- SBUX shares have climbed 23% since January, currently hovering near $104 with a consensus target of $106.45
- April brought the third consecutive quarter of positive comparable store sales performance
- Rising coffee commodity prices, tariff pressures, and delivery platform fees pose ongoing margin challenges
The Seattle-based coffee chain Starbucks (SBUX) is scheduled to unveil its third-quarter fiscal 2026 financial results Wednesday following the closing bell. Shares are currently changing hands around $104, reflecting a robust 23% gain for the year—significantly outpacing the S&P 500’s 8% advance over the same timeframe.
The Street’s consensus forecast calls for earnings of $0.65 per share alongside revenue totaling $9.12B. If realized, these figures would mark approximately a 3.6% contraction in top-line performance versus the comparable period one year ago.
During the previous quarter, Starbucks exceeded projections on both the bottom and top lines. The company delivered $9.53B in revenue, representing an 8.8% year-over-year increase. Comparable store sales metrics similarly surpassed analyst expectations.
However, projections have moderated in recent weeks. For the upcoming quarter, the analyst community is preparing for a 3% year-over-year revenue contraction—a notable shift from the 3.8% expansion recorded during Q2 of the prior fiscal year.
Looking at recent history, the coffee retailer has surpassed earnings per share forecasts in only 13% of instances over the past two years, while exceeding revenue projections 50% of the time. This inconsistent performance record has kept Wall Street’s expectations relatively conservative.
Signs of Recovery Taking Hold?
This past April, Starbucks delivered its third consecutive quarter of positive comparable sales growth following seven straight quarters of declines. Chief Executive Brian Niccol characterized the achievement as “a milestone for the business.”
RBC analyst Logan Reich indicated the company has regained positive momentum, with comparable sales benefiting from strategic labor investments, selective store closures, sales transfers to remaining locations, and expanded operating hours. RBC’s internal models anticipate Q3 performance largely consistent with Street consensus.
Reich highlighted that investors will likely focus attention during the earnings call on any updates regarding the company’s three-year initiative to achieve $2B in cost reductions.
Profitability Concerns Remain Front and Center
Not all market observers share equal optimism. Seeking Alpha’s analyst community assigns SBUX a Hold rating, while traditional Wall Street analysts generally maintain Buy recommendations.
Among the concerns raised: escalating coffee commodity prices combined with tariff implications continue applying upward pressure on input costs. Additionally, an expanding proportion of transactions occurring through delivery channels means increased revenue sharing with third-party delivery platforms.
Analyst Gary Alexander emphasized that the genuine challenge lies in whether the company can demonstrate sustained mid-to-high single-digit comparable sales growth across U.S. locations over multiple consecutive quarters. That critical question awaits a definitive answer.
Examining recent estimate adjustments over the past 90 days reveals 15 upward EPS revisions compared to five downward changes. Revenue estimate modifications have shown greater dispersion, with nine increases offset by 14 reductions.
Industry peers within the restaurant sector have delivered mixed quarterly results. Domino’s generated 4.3% year-over-year revenue growth, exceeding estimates by 1.2%, with shares advancing 1.3% following the announcement. Darden reported 13.7% revenue expansion, matching consensus projections.
Restaurant sector equities have declined 2.7% on average during the past month. SBUX shares have remained essentially unchanged over the identical timeframe.
The consensus analyst price target currently stands at $106.45, modestly above the present trading price of $104.





